← All trials
NCT05710783
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 9, 2022
- Primary completion
- Dec 28, 2022
- Completion date
- Sep 10, 2023
- First posted
- Feb 2, 2023
- Last posted
- Sep 15, 2023
- Enrollment
- 4065
- Arms / groups
- 7 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Laboratorio Avi-Mex, S.A. de C.V.Lead sponsor
- Instituto Nacional de Enfermedades RespiratoriasCollaborator
- Government of MexicoCollaborator
- Laboratorio Avi-Mex, S.A. de C.V.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.